News Headline Summary
Celgene (CELG) gets Apremilast orphan status for Behect's disease
Reaction details:
- Small move to the upside following this news, last trade at USD 99.01 (+0.15%).
Print
18:03, 17 Jan 2013 -
US Equities
- Source:
Hammerstone
Subscribe Now to RANsquawk
Click here for a 1 week free trial
RANsquawk provides audio news and commentary for over 15,000
professional traders and brokers worldwide. Services include:
-
Real-time audio coverage from 0630 to 2130 London time
-
Teams of analysts covering equities, fixed income, FX and energy markets
-
Real-time scrolling news service
-
Daily and weekly pre-market research and calendars
-
Intra-day market update videos
-
Daily technical analysis